These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25062706)

  • 1. Money and morals: ending clinical trials for financial reasons.
    Eaton ML; Kwon BK; Scott CT
    Curr Top Behav Neurosci; 2015; 19():297-315. PubMed ID: 25062706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Achieving greater independence from commercial influence in research.
    Lexchin J; Bero LA; Davis C; Gagnon MA
    BMJ; 2021 Mar; 372():n370. PubMed ID: 33687982
    [No Abstract]   [Full Text] [Related]  

  • 3. Managing Conflicts of Interest in Industry-Sponsored Clinical Research: More Physician Engagement Is Required.
    Waldstreicher J; Johns ME
    JAMA; 2017 May; 317(17):1751-1752. PubMed ID: 28464168
    [No Abstract]   [Full Text] [Related]  

  • 4. NerveCenter: Office of Inspector General warns NIH on lax COI oversight as many academic medical centers look inward.
    Samson K
    Ann Neurol; 2010 Mar; 67(3):A7-A10. PubMed ID: 20373337
    [No Abstract]   [Full Text] [Related]  

  • 5. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Better regulation of industry-sponsored clinical trials is long overdue.
    Wynia M; Boren D
    J Law Med Ethics; 2009; 37(3):410-9, 395. PubMed ID: 19723252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical research and industrial sponsoring: avenues towards transparency and credibility.
    Hildebrandt M; Ludwig WD
    Onkologie; 2003 Dec; 26(6):529-34. PubMed ID: 14709925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research accountability and financial conflicts of interest in industry-sponsored clinical research: a review.
    Tereskerz PM
    Account Res; 2003; 10(3):137-58. PubMed ID: 14979317
    [No Abstract]   [Full Text] [Related]  

  • 9. Independent medical research.
    van der Meer JW; de Gier AM; van Swaaij WP; Katan MB
    Neth J Med; 2007 Apr; 65(4):124-6. PubMed ID: 17452759
    [No Abstract]   [Full Text] [Related]  

  • 10. Ten steps to developing a national agenda to address financial conflicts of interest in industry sponsored clinical research.
    Tereskerz PM; Moreno J
    Account Res; 2005; 12(2):139-55. PubMed ID: 16220626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is it really all about the money? Reconsidering non-financial interests in medical research.
    Saver RS
    J Law Med Ethics; 2012; 40(3):467-81. PubMed ID: 23061574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why adopt a maximin theory of exploitation?
    Wertheimer A; Millum J; Schaefer GO
    Am J Bioeth; 2010 Jun; 10(6):38-9. PubMed ID: 20526968
    [No Abstract]   [Full Text] [Related]  

  • 13. Implications of pharmaceutical industry funding on clinical research.
    Lexchin JR
    Ann Pharmacother; 2005 Jan; 39(1):194-7. PubMed ID: 15562137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing financial conflicts of interest.
    IRB; 2003; 25(1):7. PubMed ID: 12833898
    [No Abstract]   [Full Text] [Related]  

  • 15. Ethical implications of for-profit corporate sponsorship of research.
    Cichy KA
    SRA J; 1990; 22(1):23-7. PubMed ID: 16047436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Justice in the application of science: beyond fair benefits.
    London AJ
    Am J Bioeth; 2010 Jun; 10(6):54-6. PubMed ID: 20526976
    [No Abstract]   [Full Text] [Related]  

  • 17. Financial remuneration for clinical and behavioral research participation: ethical and practical considerations.
    Permuth-Wey J; Borenstein AR
    Ann Epidemiol; 2009 Apr; 19(4):280-5. PubMed ID: 19230712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The perverse consequences of a proposed global tax on research.
    MacDonald C; Walton N
    Am J Bioeth; 2010 Jun; 10(6):46-7. PubMed ID: 20526972
    [No Abstract]   [Full Text] [Related]  

  • 19. [The difficult relationship of industry and science. Money versus research].
    Wessling A
    Pflege Z; 2011 Aug; 64(8):454-5. PubMed ID: 21882617
    [No Abstract]   [Full Text] [Related]  

  • 20. Industry funded clinical trials: bias and quality.
    Del Parigi A
    Curr Med Res Opin; 2012 Jan; 28(1):23-5. PubMed ID: 22103762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.